BRPI1012246A2 - composição farmacêutica contendo um fármaco e sirna - Google Patents

composição farmacêutica contendo um fármaco e sirna

Info

Publication number
BRPI1012246A2
BRPI1012246A2 BRPI1012246A BRPI1012246A BRPI1012246A2 BR PI1012246 A2 BRPI1012246 A2 BR PI1012246A2 BR PI1012246 A BRPI1012246 A BR PI1012246A BR PI1012246 A BRPI1012246 A BR PI1012246A BR PI1012246 A2 BRPI1012246 A2 BR PI1012246A2
Authority
BR
Brazil
Prior art keywords
sirna
drug
pharmaceutical composition
composition containing
pharmaceutical
Prior art date
Application number
BRPI1012246A
Other languages
English (en)
Inventor
Giancarlo Francese
Michael Keller
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI1012246A2 publication Critical patent/BRPI1012246A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1012246A 2009-03-25 2010-03-24 composição farmacêutica contendo um fármaco e sirna BRPI1012246A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09156232 2009-03-25
PCT/EP2010/053802 WO2010108934A1 (en) 2009-03-25 2010-03-24 Pharmaceutical composition containing a drug and sirna

Publications (1)

Publication Number Publication Date
BRPI1012246A2 true BRPI1012246A2 (pt) 2016-03-29

Family

ID=41100625

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1012246A BRPI1012246A2 (pt) 2009-03-25 2010-03-24 composição farmacêutica contendo um fármaco e sirna

Country Status (11)

Country Link
US (1) US20120015026A1 (pt)
EP (1) EP2410988A1 (pt)
JP (1) JP2012521389A (pt)
KR (1) KR20120013336A (pt)
CN (1) CN102361631A (pt)
AU (1) AU2010227549B2 (pt)
BR (1) BRPI1012246A2 (pt)
CA (1) CA2756499A1 (pt)
MX (1) MX2011010045A (pt)
RU (1) RU2011142620A (pt)
WO (1) WO2010108934A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0924862A2 (pt) 2009-06-12 2016-08-23 Abb Technology Ag meio de isolação dielétrica
DE202009009305U1 (de) 2009-06-17 2009-11-05 Ormazabal Gmbh Schalteinrichtung für Mittel-, Hoch- oder Höchstspannung mit einem Füllmedium
WO2011108955A1 (en) * 2010-03-03 2011-09-09 Universidade De Coimbra Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s)
CA2840339A1 (en) * 2010-06-23 2011-12-29 Brightside Innovations, Inc. Lecithin carrier vesicles and methods of making the same
WO2012080246A1 (en) 2010-12-14 2012-06-21 Abb Technology Ag Dielectric insulation medium
US9636410B2 (en) * 2011-07-06 2017-05-02 Glaxosmithkline Biologicals Sa Cationic oil-in-water emulsions
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
WO2013087700A1 (en) 2011-12-13 2013-06-20 Abb Technology Ag Sealed and gas insulated high voltage converter environment for offshore platforms
CN103536920A (zh) * 2012-07-10 2014-01-29 复旦大学 一种抑制胰腺癌细胞增殖的药物组合物及其应用
KR101586790B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101601035B1 (ko) 2013-02-28 2016-03-08 주식회사 종근당 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물
CA3120574A1 (en) 2013-03-14 2014-09-25 Dicerna Pharmaceuticals, Inc. Process for formulating an anionic agent
WO2015009544A1 (en) * 2013-07-11 2015-01-22 Texas Heart Institute Rna interference of fabp4 for the treatment of atherosclerosis
CN103599549A (zh) * 2013-11-22 2014-02-26 大连民族学院 一种siRNA/抗癌药物联合转运复合载体及其制备方法和应用
CN104258416B (zh) * 2014-09-25 2018-05-25 山东大学 基于寡聚核苷酸共递送药物和基因的纳米载体及制备方法
CA2977397A1 (en) 2015-03-03 2016-09-09 Cureport, Inc. Dual loaded liposomal pharmaceutical formulations
WO2016141167A1 (en) 2015-03-03 2016-09-09 Cureport, Inc. Combination liposomal pharmaceutical formulations
CN107746857B (zh) * 2017-08-07 2021-02-05 中国农业大学 一种抑制基因表达的rna干扰方法
CN109419773B (zh) * 2017-08-23 2022-06-17 上海交通大学医学院附属仁济医院 复合纳米脂质给药系统及其对妇科肿瘤的治疗作用
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
CN112870373B (zh) * 2021-04-02 2022-12-30 四川大学 用于mRNA递送的多肽聚合物复合纳米颗粒及其制备方法和用途
CN113908288B (zh) * 2021-09-29 2023-10-13 深圳市人民医院 一种mRNA递送系统及其制备方法和应用
JPWO2023229023A1 (pt) * 2022-05-25 2023-11-30
WO2024049164A1 (ko) * 2022-08-30 2024-03-07 한양대학교 산학협력단 세포막 유래 핵산 전달용 나노소낭 및 이의 제조 방법

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4402867C1 (de) * 1994-01-31 1995-06-14 Rentschler Arzneimittel Liposomen enthaltend darin verkapselte Proteine, Verfahren zu ihrer Herstellung sowie diese Liposomen enthaltende pharmazeutische und kosmetische Zubereitungen
ATE247971T1 (de) * 1995-08-01 2003-09-15 Novartis Erfind Verwalt Gmbh Liposomale oligonukleotidzusammensetzungen
US6302838B1 (en) * 1998-02-25 2001-10-16 Novartis Ag Cancer treatment with epothilones
JP2003504322A (ja) * 1999-07-07 2003-02-04 カナダ国 リポソームにより被包された抗酸化剤の送達およびその適用
GB9918429D0 (en) 1999-08-04 1999-10-06 Novartis Ag Organic compounds
ES2331791T5 (es) * 2002-06-26 2016-01-21 Medigene Ag Método de producción de una preparación catiónica de liposomas que comprende un compuesto lipófilo
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
US7749485B2 (en) * 2004-06-03 2010-07-06 Bracco Research S.A. Liposomal assembly for therapeutic and/or diagnostic use
JP2008518925A (ja) * 2004-10-29 2008-06-05 ネオファーム、インコーポレイティッド リポソーム製剤の製造プロセス
US8895717B2 (en) * 2005-04-15 2014-11-25 The Board Of Regents Of The University Of Texas System Delivery of siRNA by neutral lipid compositions
AU2007306556B2 (en) * 2006-10-13 2014-04-10 Marina Biotech, Inc. Improvements in or relating to amphoteric liposomes
TW200819137A (en) * 2006-10-31 2008-05-01 Iner Aec Executive Yuan Method for preparation of lipid-spacer radical- reactions of functional group-peptide
CA2673622A1 (en) * 2006-12-22 2008-07-03 Imuthes Limited Lipid
WO2008105178A1 (ja) * 2007-02-28 2008-09-04 National University Corporation Hokkaido University リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム
WO2008109432A2 (en) * 2007-03-02 2008-09-12 The Board Of Regents Of The University Of Texas System Therapeutic targeting of interleukins using sirna in neutral liposomes
WO2008109105A2 (en) * 2007-03-06 2008-09-12 Flagship Ventures Methods and compositions for improved therapeutic effects with sirna
EP2153820A4 (en) * 2007-05-14 2013-12-25 Konica Minolta Holdings Inc LIPOSOM AND METHOD FOR THE PRODUCTION OF LIPOSOMY
US9006191B2 (en) * 2007-12-27 2015-04-14 Protiva Biotherapeutics, Inc. Silencing of polo-like kinase expression using interfering RNA
US20110038941A1 (en) * 2007-12-27 2011-02-17 The Ohio State University Research Foundation Lipid Nanoparticle Compositions and Methods of Making and Using the Same
US20100129430A1 (en) * 2008-11-24 2010-05-27 Stavroula Sofou Liposome drug carriers with ph-sensitivity

Also Published As

Publication number Publication date
CA2756499A1 (en) 2010-09-30
US20120015026A1 (en) 2012-01-19
KR20120013336A (ko) 2012-02-14
MX2011010045A (es) 2011-10-11
WO2010108934A1 (en) 2010-09-30
EP2410988A1 (en) 2012-02-01
JP2012521389A (ja) 2012-09-13
CN102361631A (zh) 2012-02-22
AU2010227549B2 (en) 2014-02-27
RU2011142620A (ru) 2013-04-27
AU2010227549A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
DK2414011T3 (da) Medikamentafgivelsesindretning
DK2493532T3 (da) Lægemiddelfremføringsanordning
BR112012011902A2 (pt) cápsula farmacêutica
DK2296732T3 (da) Medikamentafgivelsesindretning
DK3756657T3 (da) Synkbar anordning til lægemiddelfremføring
BRPI1010279A2 (pt) dispositivo de distribuição de fármaco
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1004940A2 (pt) composição farmacêutica
SMT201700095B (is) Composizioni farmaceutiche per inalazione
BRPI1012730A2 (pt) dispositivo de distribuição de fármaco
BRPI1008900A2 (pt) mecanismo de recipiente e de distribuição de fármaco
DK2658525T3 (da) Bionedbrydelig lægemiddelafgivelsessammensætning
BRPI0920514A2 (pt) infusão de fármacos
BRPI1011728A2 (pt) dispositivo de administração de fármacos restaurável
DK2403569T3 (da) Lægemiddelafgivelsesanordning med tilbagetrækkelig nål
DK2274030T4 (da) Lægemiddelafgivelsesanordning
DK2274029T3 (da) Lægemiddelafgivelsesanordning
BRPI1010237A2 (pt) dispositivo de distribuição de fármaco
DK2398500T3 (da) Glutathion-baseret lægemiddelafgivelsessystem
EP2451274A4 (en) Pharmaceutical compositions
EP2419097A4 (en) PHARMACEUTICAL COMPOSITIONS
SMT201400069B (it) Formulazione farmaceutica
BRPI1012578A2 (pt) conjunto para um dispositivo para distribuição de fármaco e dispositivo para distribuição de fármaco
DK2381988T3 (da) Medikamentadministrationsanordning
DK3360575T3 (da) Transdermale farmaceutiske sammensætninger omfattende aktive stoffer

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.